Nektar Therapeutics (NKTR)
1.30
-0.05
(-3.70%)
USD |
NASDAQ |
Apr 18, 16:00
1.30
0.00 (0.00%)
After-Hours: 20:00
Nektar Therapeutics Total Assets (Quarterly): 398.03M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 398.03M |
| September 30, 2023 | 442.24M |
| June 30, 2023 | 494.28M |
| March 31, 2023 | 561.74M |
| December 31, 2022 | 710.60M |
| September 30, 2022 | 781.01M |
| June 30, 2022 | 861.99M |
| March 31, 2022 | 1.024B |
| December 31, 2021 | 1.117B |
| September 30, 2021 | 1.277B |
| June 30, 2021 | 1.371B |
| March 31, 2021 | 1.457B |
| December 31, 2020 | 1.539B |
| September 30, 2020 | 1.509B |
| June 30, 2020 | 1.595B |
| March 31, 2020 | 1.888B |
| December 31, 2019 | 1.977B |
| September 30, 2019 | 2.088B |
| June 30, 2019 | 2.100B |
| March 31, 2019 | 2.166B |
| December 31, 2018 | 2.150B |
| September 30, 2018 | 2.249B |
| June 30, 2018 | 2.313B |
| March 31, 2018 | 496.79M |
| December 31, 2017 | 508.87M |
| Date | Value |
|---|---|
| September 30, 2017 | 582.06M |
| June 30, 2017 | 475.86M |
| March 31, 2017 | 528.49M |
| December 31, 2016 | 568.87M |
| September 30, 2016 | 425.10M |
| June 30, 2016 | 463.10M |
| March 31, 2016 | 491.88M |
| December 31, 2015 | 498.64M |
| September 30, 2015 | 449.25M |
| June 30, 2015 | 456.67M |
| March 31, 2015 | 499.21M |
| December 31, 2014 | 441.62M |
| September 30, 2014 | 476.90M |
| June 30, 2014 | 478.14M |
| March 31, 2014 | 487.01M |
| December 31, 2013 | 434.53M |
| September 30, 2013 | 383.04M |
| June 30, 2013 | 412.81M |
| March 31, 2013 | 447.90M |
| December 31, 2012 | 497.79M |
| September 30, 2012 | 541.45M |
| June 30, 2012 | 668.44M |
| March 31, 2012 | 694.79M |
| December 31, 2011 | 606.55M |
| September 30, 2011 | 648.09M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
398.03M
Minimum
Dec 2023
2.100B
Maximum
Jun 2019
1.221B
Average
1.277B
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Stereotaxis Inc | 41.91M |
| Vanda Pharmaceuticals Inc | 648.44M |
| Cara Therapeutics Inc | 125.84M |
| Marinus Pharmaceuticals Inc | 170.91M |
| DiaMedica Therapeutics Inc | 54.16M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 267.05M |
| Shareholders Equity (Quarterly) | 130.99M |
| Current Ratio | 6.450 |